Peru · Buyer: INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICASDirecta-Directa-1-2026-Inen-1
AwardedPEN 8,316,000
Published2/25/2026Published
Submission deadlineNot specifiedNot specified
Description
ADQUISICIÓN DEL PRODUCTO FARMACÉUTICO BLINATUMOMAB 35 UG INY
Otnox Intelligence
Loading...
Tender documents
Loading...
Buyer activity
Tenders—last 12 months
Avg contract—last 12 months
Total spend—last 12 months
Loading...
Contact Information
- Company
- INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS
- Contact person
- Phone
INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICASINSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICASINSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICASINSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICASINSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICASINSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICASCENTRO NACIONAL DE ABASTECIMIENTO DE RECURSOS ESTRATEGICOS EN SALUDMUNICIPALIDAD DISTRITAL DE CHILIQUININSTITUTO PERUANO DEL DEPORTEMUNICIPALIDAD DISTRITAL DE INCLANMUNICIPALIDAD DISTRITAL DE SAN MIGUEL CHACCRAMPAFind tenders worth bidding for.
Create an account to explore this tender and find similar opportunities.
- Tender documentsReview available files in one workspace.
- Requirements and risksRequest a document analysis with references to the sources.
- Your tender selectionContinue with your selected markets and sectors.